Related Experiment Video
Updated: Jan 27, 2026

Monitoring Dynamic Changes In Mitochondrial Calcium Levels During Apoptosis Using A Genetically Encoded Calcium Sensor
Published on: April 1, 2011
Selenium attenuates docetaxel-induced apoptosis and mitochondrial oxidative stress in kidney cells
Ercan Baş1, Mustafa Naziroğlu2,3
1Department of Urology, Faculty of Medicine.
Abstract:
Docetaxel (DTX) is a chemotherapeutic agent, and it is used for the treatment of several cancers including prostate and glioblastoma, but it results in many adverse effects in normal tissues, including kidney. The cytoprotective properties of selenium (Se) against adverse effects of DTX were reported in several normal cells, except kidney cell lines. The purpose of this study was to investigate the effects of Se on DTX-induced nephrotoxicity in normal kidney cell lines. The human embryonic kidney 293 (HEK293) cells were divided into four groups as control, Se (200 nmol/l for 10 h), DTX (10 nmol/l for 48 h), and DTX+Se. Laser confocal microscope fluorescence intensity of apoptosis (annexin V and propidium iodide), mitochondrial membrane depolarization, reactive oxygen species production, and lipid peroxidation levels were increased in the cells by the DTX treatments, although cell number, cell viability, reduced glutathione and glutathione peroxidase values were decreased by the treatments. The fluorescence intensities and values were recovered in the DTX+Se group of the cells by Se treatment. In conclusion, DTX-induced adverse effects were recovered through inhibition of apoptosis and mitochondrial oxidative stress through upregulation of reduced glutathione and glutathione peroxidase in the normal kidney (HEK293) cells. Combination therapy of DTX and Se could be used as an effective strategy for protection of kidney cells against adverse effects of DTX.
Insights
Selenium (Se) protects kidney cells from docetaxel (DTX)-induced toxicity by reducing apoptosis and oxidative stress. This combination therapy shows promise for preventing adverse effects in normal kidney cells during cancer treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Docetaxel (DTX) is a chemotherapy drug used for various cancers.
- DTX causes adverse effects in normal tissues, particularly the kidney.
- Selenium (Se) has shown cytoprotective effects in normal cells against DTX, but its effect on kidney cells is unexplored.
Purpose of the Study:
- To investigate the protective effects of selenium (Se) against docetaxel (DTX)-induced nephrotoxicity.
- To evaluate Se's impact on DTX-induced damage in normal kidney cell lines.
Main Methods:
- Human embryonic kidney 293 (HEK293) cells were used.
- Cells were divided into four groups: control, Se-treated, DTX-treated, and DTX+Se treated.
- Assessed apoptosis, mitochondrial membrane potential, reactive oxygen species (ROS), lipid peroxidation, cell viability, reduced glutathione, and glutathione peroxidase.
Main Results:
- DTX treatment increased apoptosis, mitochondrial depolarization, ROS production, and lipid peroxidation.
- DTX decreased cell number, viability, reduced glutathione, and glutathione peroxidase.
- Selenium treatment in the DTX+Se group reversed these DTX-induced changes, indicating protection.
Conclusions:
- Selenium mitigates docetaxel-induced nephrotoxicity in normal kidney cells.
- Se protects kidney cells by inhibiting apoptosis and oxidative stress, upregulating glutathione and glutathione peroxidase.
- Combined DTX and Se therapy is a potential strategy to protect kidney cells from chemotherapy side effects.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Apoptosis
Animal Mitochondrial Genetics
Oxidation Numbers
Kidney Structure
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

